Skip to main content
. 2023 Sep 19;12(18):6048. doi: 10.3390/jcm12186048

Table 3.

Changes in the primary outcome of balloon expandable TAVR trials.

Surgical Risk Year Trial Primary Outcome
Extreme 2010 PARTNER 1B [21] Death
High 2011 PARTNER 1A [11] Death
Intermediate 2016 PARTNER 2 [9] Death or disabling stroke
Low 2019 PARTNER 3 [10] Death, stroke, or rehospitalization due to the procedure, valve, or heart failure

PARTNER = placement of aortic transcatheter valves. TAVR = transcatheter aortic valve replacement.